Refine
Has Fulltext
- yes (2)
Is part of the Bibliography
- yes (2)
Document Type
- Journal article (1)
- Doctoral Thesis (1)
Keywords
- BCOR (1)
- BCORL1 (1)
- Involution (1)
- Morphometrie (1)
- Myasthenia gravis (1)
- Thymus (1)
- acute myeloid leukemia (1)
- involution (1)
- loss-of-function (1)
- morphometry (1)
Institute
Der Thymus unterliegt einer altersabhängigen Involution. Dieses Phämomen soll in dieser Arbeit mit morphometrischen Mitteln untersucht werden. Mit Hilfe der Farbdifferenzanalyse wird der Anteil von Thymusgewebe im mediastinalen Fettgewebe festgestellt. Weiterhin wird die Veränderung des Thymus bei der Autoimmunkrankheit Myasthenia gravis untersucht.
Acute myeloid leukemia (AML) is characterized by recurrent genetic events. The BCL6 corepressor (BCOR) and its homolog, the BCL6 corepressor-like 1 (BCORL1), have been reported to be rare but recurrent mutations in AML. Previously, smaller studies have reported conflicting results regarding impacts on outcomes. Here, we retrospectively analyzed a large cohort of 1529 patients with newly diagnosed and intensively treated AML. BCOR and BCORL1 mutations were found in 71 (4.6%) and 53 patients (3.5%), respectively. Frequently co-mutated genes were DNTM3A, TET2 and RUNX1. Mutated BCORL1 and loss-of-function mutations of BCOR were significantly more common in the ELN2017 intermediate-risk group. Patients harboring loss-of-function mutations of BCOR had a significantly reduced median event-free survival (HR = 1.464 (95%-Confidence Interval (CI): 1.005–2.134), p = 0.047), relapse-free survival (HR = 1.904 (95%-CI: 1.163–3.117), p = 0.01), and trend for reduced overall survival (HR = 1.495 (95%-CI: 0.990–2.258), p = 0.056) in multivariable analysis. Our study establishes a novel role for loss-of-function mutations of BCOR regarding risk stratification in AML, which may influence treatment allocation.